Control Bionics Limited (ASX:CBL)
0.0450
0.00 (0.00%)
Aug 4, 2025, 4:10 PM AEST
Everbridge Revenue
Control Bionics had revenue of 2.90M AUD in the half year ending December 31, 2024, a decrease of -0.09%. This brings the company's revenue in the last twelve months to 5.28M, down -7.44% year-over-year. In the fiscal year ending June 30, 2024, Control Bionics had annual revenue of 5.35M, down -5.17%.
Revenue (ttm)
5.28M
Revenue Growth
-7.44%
P/S Ratio
2.51
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.26M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.35M | -291.61K | -5.17% |
Jun 30, 2023 | 5.64M | 1.14M | 25.33% |
Jun 30, 2022 | 4.50M | 413.43K | 10.11% |
Jun 30, 2021 | 4.09M | 886.39K | 27.68% |
Jun 30, 2020 | 3.20M | 2.31M | 257.25% |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 24.61B |
Pro Medicus | 184.58M |
Cochlear | 2.31B |
Sonic Healthcare | 9.33B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 783.21M |
Ansell | 3.00B |
Mesoblast | 9.16M |